High-Content Imaging Workflow for Single-Cell Drug Response Profiling of Acute Myeloid Leukemia Subtypes.
Acute myeloid leukemia (AML) exhibits pronounced cellular heterogeneity, which contributes to variable therapeutic responses and limits the predictive power of conventional functional assays. While bulk viability measurements provide aggregated readouts, they fail to resolve phenotypic diversity and dynamic cellular st...